dr.senthilnathan presentation
Post on 20-Oct-2014
544 views
DESCRIPTION
TRANSCRIPT
FIRST SAI SIDDHA GET TOGETHER
DATE:05-aug-12
SAFETY SIDDHA DRUG PROFILE
Dr.S.SENTHILNATHAN,
THE CHILDS TRUST MEDICAL FOUNDATION, KKKCTH,
CHENNAI.
ADVERSE EVENT/ADVERSE DRUG REACTIONAny untoward medical occurrence (including a
symptom / disease or an abnormal laboratory
finding) during treatment with a
pharmaceutical product in a patient or a
human volunteer that does not necessarily
have a relationship with the treatment being
given.
SERIOUS ADVERSE EVENTA serious adverse event (experience) or reaction is
any untoward medical occurrence that at any dose: Results in death,
Is life-threatening,
(NOTE: The term "life-threatening" in the definition of "serious" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.)
Requires Inpatient Hospitalization or prolongation of existing Hospitalization,
Results in persistent or significant Disability / Incapacity, or
Is a Congenital Anomaly / Birth defect.
SIGNIFICANCE OF AE• Rofecoxib (NSAID)was approved as safe and
effective by the Food and Drug Administration (FDA) on May 20, 1999 and was subsequently marketed under the brand name Vioxx, Ceoxx and Ceeoxx.
• In April 2002, warnings on Vioxx labelling concerning the increased risk of cardiovascular events (Heart attack and Stroke) associated with long-term, high-dosage use were issued .
Cont…A blockbuster drug that had been marketed in
more than 80 countries with worldwide sales totaling $2.5 billion in 2003.
On September 30, 2004, Merck voluntarily withdrew Rofecoxib from the market because of concerns about increased risk of Myocardial Infarction and Stroke
DRUG WITHDRAWN FROM MARKET • Nimesulide, cisapride and
phenylpropanolamine were found serious side effects since early 2000 and many developed countries had already banned all of them.
• DCGI waked up little late and ordered examining safety profile.
• Banned Drugs.
REPORTING AE AE form
Adverse Event
NON SERIOUS SERIOUSRecord in CRF
Record in CRF
Report EXPEDITEDLY
ETHICS COMMITTEE
SPONSOR DSMB
REGULATORY AUTHORITY DCGI
14 Calendar days
24 Hours
7 Calendar days
IMPLEMENTING AE REPORTING IN SIDDHA
MEDICINE